(Q37263193)

19 August 2017

1 reference

title

Use of somatostatin analogues in obesity (English)

1 reference

19 August 2017

0 references

Themistoklis Tzotzas

1

1 reference

19 August 2017

Kostas Papazisis

series ordinal

2

1 reference

19 August 2017

Petros Perros

series ordinal

3

1 reference

19 August 2017

Gerasimos E Krassas

series ordinal

4

1 reference

19 August 2017

publication date

1 January 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

68

1 reference

19 August 2017

issue

14

1 reference

19 August 2017

page(s)

1963-1973

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200868140-00003

19 August 2017

exact match

0 references

cites work

Molecular pharmacology of somatostatin receptor subtypes

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868140-00003

Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868140-00003

Peptide-binding G protein-coupled receptors: new opportunities for drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868140-00003

Weight gain in craniopharyngioma--a model for hypothalamic obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868140-00003

Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegaly

21 January 2018

1 reference

12 December 2020

The MONA LISA hypothesis in the time of leptin.

1 reference

12 December 2020

Effects of the somatostatin analogue, octreotide, in polycystic ovary syndrome

1 reference

12 December 2020

Prevalence and trends of obesity in children and adults of South Europe.

1 reference

12 December 2020

The gut and energy balance: visceral allies in the obesity wars

1 reference

12 December 2020

1 reference

12 December 2020

Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating

1 reference

12 December 2020

The obesity epidemic is a worldwide phenomenon

1 reference

12 December 2020

Ghrelin immunoreactivity in human plasma is suppressed by somatostatin

1 reference

12 December 2020

1 reference

12 December 2020

The effects of insulin on the central nervous system--focus on appetite regulation

1 reference

12 December 2020

Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity.

1 reference

12 December 2020

Growth hormone treatment improves body composition in adults with Prader–Willi syndrome

1 reference

12 December 2020

Effect of octreotide on glucose tolerance in acromegaly.

1 reference

12 December 2020

Operations that are Questionable for Control of Obesity

1 reference

12 December 2020

Insulin normalization as an approach to the pharmacological treatment of obesity

1 reference

12 December 2020

Effect of somatostatin analog on postprandial satiation in obesity

1 reference

12 December 2020

Manifestations of hypothalamic obesity in man: a comprehensive investigation of eight patients and a reveiw of the literature

1 reference

12 December 2020

Investigational therapies in the treatment of obesity

1 reference

12 December 2020

Integrative physiology of human adipose tissue

1 reference

12 December 2020

Insulin-sensitizing agents in women with polycystic ovary syndrome

1 reference

12 December 2020

Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma.

1 reference

12 December 2020

Neural representations of hunger and satiety in Prader-Willi syndrome

1 reference

12 December 2020

Somatostatin decreases food intake of rats and baboons

1 reference

12 December 2020

Neural mechanisms underlying hyperphagia in Prader-Willi syndrome

1 reference

12 December 2020

Truncal vagotomy in hypothalamic obesity

1 reference

12 December 2020

Acute postchallenge hyperinsulinemia predicts weight gain: a prospective study

1 reference

12 December 2020

Inhibition of growth hormone-stimulated lipolysis by somatostatin, insulin, and insulin-like growth factors (somatomedins) in vitro

1 reference

12 December 2020

The role of vagally-medicated hyperinsulinemia in hypothalamic obesity

1 reference

12 December 2020

Divergent effects of octreotide on glucose tolerance in patients with acromegaly

1 reference

12 December 2020

Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution

1 reference

12 December 2020

Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults

1 reference

12 December 2020

Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children

1 reference

12 December 2020

Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans

1 reference

12 December 2020

Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities

1 reference

12 December 2020

Elevated plasma ghrelin levels in Prader–Willi syndrome

1 reference

12 December 2020

Clinical and pathophysiological aspects of somatostatin and the gastrointestinal tract

1 reference

12 December 2020

Hypothalamic obesity in humans: what do we know and what can be done?

1 reference

12 December 2020

Genetics of human obesity

1 reference

12 December 2020

An autonomic hypothesis for hypothalamic obesity

1 reference

12 December 2020

Efficacy of octreotide-LAR in dieting women with abdominal obesity and polycystic ovary syndrome

1 reference

12 December 2020

Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).

1 reference

12 December 2020

Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice

1 reference

12 December 2020

Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity.

1 reference

12 December 2020

Dose response to insulin in man: differential effects on glucose and ketone body regulation

1 reference

12 December 2020

Molecular mechanisms of insulin resistance and associated diseases

1 reference

12 December 2020

Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist

1 reference

12 December 2020

Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis

1 reference

12 December 2020

Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial

1 reference

12 December 2020

Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes

1 reference

12 December 2020

Neuroendocrine control of food intake

1 reference

12 December 2020

Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels

1 reference

12 December 2020

Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome

1 reference

12 December 2020

Use of somatostatin receptor ligands in obesity and diabetic complications

1 reference

12 December 2020

The hypothalamus, hormones, and hunger: alterations in human obesity and illness

1 reference

12 December 2020

Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome

1 reference

12 December 2020

The descriptive epidemiology of craniopharyngioma.

1 reference

12 December 2020

Molecular biology of somatostatin receptors

1 reference

12 December 2020

Racial and etiopathologic dichotomies in insulin hypersecretion and resistance in obese children

1 reference

12 December 2020

Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma.

1 reference

12 December 2020

The Antilipolytic Action of Insulin in Obese Subjects with Resistance to Its Glucoregulatory Action*

1 reference

12 December 2020

The efficacy of somatostatin analogues in the treatment of diabetic retinopathy and thyroid eye disease.

1 reference

12 December 2020

A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion

1 reference

12 December 2020

Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogues treatment.

1 reference

12 December 2020

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

1 reference

12 December 2020

Imprinting in Prader-Willi and Angelman syndromes

1 reference

12 December 2020

Measurement of excessive appetite and metabolic changes in Prader-Willi syndrome

1 reference

12 December 2020

Production of insulin resistance by hyperinsulinaemia in man.

1 reference

12 December 2020

The future of somatostatin analogue therapy

1 reference

12 December 2020

Suppression of insulin secretion is associated with weight loss and altered macronutrient intake and preference in a subset of obese adults

1 reference

12 December 2020

Peripherally administered somatostatin reduces feeding by a vagal mediated mechanism

1 reference

12 December 2020

A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.

1 reference

12 December 2020

Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects.

1 reference

12 December 2020

Regulation of ghrelin secretion by somatostatin analogs in rats

1 reference

12 December 2020

Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group

1 reference

12 December 2020

Somatostatin inhibits insulin secretion by a G-protein-mediated decrease in Ca2+ entry through voltage-dependent Ca2+ channels in the beta cell

1 reference

12 December 2020

10.2165/00003495-200868140-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

19 August 2017

1029864224

0 references

1 reference